Ovarian Mass with Elevated LDH: Dysgerminoma Until Proven Otherwise
An ovarian mass with serum LDH of 818 U/L strongly suggests dysgerminoma (ovarian germinoma), a malignant germ cell tumor, and requires immediate comprehensive tumor marker evaluation followed by surgical staging with fertility-sparing approach if appropriate.
Diagnostic Significance of Elevated LDH
The LDH level of 818 U/L is markedly elevated (normal range typically <250 U/L) and is highly characteristic of dysgerminoma. Multiple studies demonstrate that dysgerminomas consistently produce extreme elevations of serum LDH—significantly higher than any other ovarian tumor type 1. In fact, LDH serves as a specific tumor marker for dysgerminoma 2, with all reported cases showing "extremely high levels" preoperatively 3.
The pattern is distinctive: dysgerminomas elevate the fast-moving LDH isoenzymes (LDH-1, LDH-2, and LDH-3), whereas epithelial ovarian cancers elevate the slow fractions 4, 5, 3. This LDH elevation typically returns to normal within 2 weeks after complete tumor excision 4, 5, 6, 7.
Immediate Workup Required
Complete the following tumor marker panel immediately 1:
- AFP (alpha-fetoprotein) - to exclude yolk sac tumor, embryonal carcinoma, or mixed germ cell tumor
- β-hCG (beta-human chorionic gonadotropin) - to exclude choriocarcinoma, embryonal carcinoma, or mixed elements
- LDH isoenzymes - fast fractions (LDH-1,2,3) support dysgerminoma
- CA-125 - typically not elevated in pure dysgerminoma but helps exclude epithelial tumors
Imaging staging 1:
- MRI pelvis - preferred in young patients to characterize the mass and avoid radiation exposure
- CT chest/abdomen/pelvis - if MRI unavailable, to assess for metastatic disease
- Look for solid mass appearance on imaging, which raises suspicion for dysgerminoma in young patients 1
Critical Management Principles
Surgical Approach
Fertility-sparing surgery is the standard of care 1:
- Unilateral salpingo-oophorectomy with peritoneal washings
- Avoid radical surgery and full staging procedures - they are unnecessary and inappropriate 1
- Do NOT perform routine lymphadenectomy - the efficacy of salvage chemotherapy makes aggressive staging unnecessary 1
- Peritoneal biopsies and omentectomy only if clinically indicated
- Preserve the contralateral ovary unless grossly involved
This conservative approach is justified because: (1) most dysgerminomas are stage I, (2) chemotherapy is highly effective for residual disease, and (3) these tumors occur predominantly in young women of reproductive age 1.
Adjuvant Therapy Decision Algorithm
Stage IA dysgerminoma → Observation only 1
Stage IB or higher, or incompletely resected disease → BEP chemotherapy (bleomycin, etoposide, cisplatin):
- 3 cycles for completely resected stage I
- 4 cycles for advanced disease 8
Important caveat: Do NOT give bleomycin to patients >40 years old or with pre-existing pulmonary disease due to 3% mortality risk from drug-related lung injury 8.
Follow-Up Protocol
Dysgerminomas relapse early (typically within 12-18 months) 1, so intensive early surveillance is critical:
Years 1-2 8:
- Physical examination with pelvic exam every 3 months
- Serum LDH levels every 3 months (primary marker)
- AFP and β-hCG if initially elevated
- Imaging (MRI preferred over CT to minimize radiation) only if tumor markers rise or clinical symptoms develop
Year 3 8:
- Every 6 months
Beyond year 3:
- Annually
Common Pitfalls to Avoid
Do not delay surgery for tissue diagnosis if the patient is medically unstable with high tumor burden—substantially elevated LDH with AFP/β-hCG can be sufficient for diagnosis and treatment initiation 9
Do not perform biopsy of the normal-appearing contralateral ovary unless there is visible involvement 10
Do not assume epithelial ovarian cancer based on CA-125 alone—the LDH elevation pattern is pathognomonic for germ cell tumors
Do not use LDH for epithelial ovarian cancer diagnosis—while LDH correlates with stage/grade in epithelial cancers 11, 12, 13, it lacks the diagnostic specificity seen in dysgerminoma
Recognize that LDH can be falsely elevated by hemolysis, strenuous exercise, liver disease, myocardial infarction, or pneumonia 9—but an LDH of 818 U/L in the context of an ovarian mass is highly specific
The prognosis for dysgerminoma is excellent with appropriate treatment, with cure rates exceeding 90% even for advanced disease when platinum-based chemotherapy is used 1, 8.